MJFF GBA1 Parkinson's Disease Research Catalyst Program
Connects United States Parkinson's researchers through the MJFF GBA1 Catalyst Program for precision treatment design and testing.
The Michael J. Fox Foundation GBA1 Parkinson's Disease Research Catalyst Program funds investigator-initiated research into GBA1-associated Parkinson's disease, one of the most common genetic risk factors for the condition. MJFF, which has invested more than $2 billion in PD research since 2000, designed the Catalyst Program specifically to build mechanistic understanding of how GBA1 dysfunction d…
Funds research into GBA1-associated Parkinson's disease, including molecular mechanisms linking GBA1 dysfunction to neurodegeneration, disease modifiers, progression factors, and cell-type or systems-level effects.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
BudgetGrant Budget Justification: How to Write the Budget Narrative
Learn how to write a grant budget justification, explain R&D costs, avoid weak budget narratives, and connect each cost to your work plan.
DocumentsGrant Checklist: Application Documents, Forms, and Examples
Use this grant checklist to see the documents, forms, narratives, budgets, evidence, and compliance attachments a grant application may require.
More from MJFF
All grants from this funder →MJFF Targets to Therapies: Mitochondrial Target Validation
MJFF · United States
Supports mitochondrial target validation in Parkinson's research to build stronger therapy-ready evidence.
MJFF Therapeutics Pipeline Program — Pre-Proposals
MJFF · United States
Supports Parkinson's disease research teams in the MJFF Therapeutics Pipeline with sustained coaching toward therapeutic candidate development.
Edmond J. Safra Fellowship in Movement Disorders — Class of
MJFF · United States
Offers long-form fellowship support for movement disorder physicians and researchers in global academic centers.
MJFF Access Advocate for Clinical Research Participation
🇺🇸MJFF · United States
Supports structured trial access advocacy in Parkinson's programs by strengthening participant pathways at sites.
MJFF Parkinson's Disease Proteoforms Program
MJFF · United States
Funds proteoform-focused Parkinson's research to strengthen molecular evidence and translational targets.
Similar grants
Browse the directory →
Parkinson's UK Drug Accelerator Awards
🇬🇧Parkinson's UK · United Kingdom
Funds translational Parkinson's drug discovery in the United Kingdom to generate partnership-ready preclinical evidence.
Research to Business Grant
🇫🇮Business Finland · Finland
Supports Finnish public research organizations converting laboratory outcomes into commercial products and services.
Parkinson's Foundation Stanley Fahn Junior Faculty Award
🇺🇸Parkinson's Foundation · United States
Funds early-career Parkinson's disease researchers at United States and Canada institutions through independent investigator support.
NIH IGNITE Program — R61/R33 Phased Neurotherapeutic Grants
🇺🇸NIH · United States
Supports early neurotherapeutic translation through milestone-based translational funding.
NCATS STTR Phase I
🇺🇸NCATS · United States
Funds U.S. small businesses and their nonprofit research partners to conduct feasibility studies on translational science innovations toward commercialization.
Making America Healthy Again — Dementia Disparities (OMH) — Seed
🇺🇸HHS · United States
Supports community-based teams reducing dementia and brain-health disparities in underserved groups through social-determinant-focused strategies.